Ignite Creation Date:
2025-12-24 @ 10:23 PM
Ignite Modification Date:
2025-12-25 @ 7:55 PM
Study NCT ID:
NCT06722235
Status:
RECRUITING
Last Update Posted:
2025-12-18
First Post:
2024-12-05
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Sponsor:
Takeda
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-02-27
Start Date Type:
ACTUAL
Primary Completion Date:
2027-12-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12-28
Completion Date Type:
ESTIMATED
First Submit Date:
2024-12-05
First Submit QC Date:
None
Study First Post Date:
2024-12-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-16
Last Update Post Date:
2025-12-18
Last Update Post Date Type:
ESTIMATED